期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
Prevalence of non-tuberculosis mycobacteria among samples deposited from the National Tuberculous Reference Laboratory of Iran(2011-2018)
1
作者 Saman Ayoubi Parissa Farnia +3 位作者 Poopak Farnia Jafar Aghajani Jalaledin Ghanavi Ali Akbar Velayati 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2021年第10期451-456,共6页
Objective:To investigate the prevalence of non-tuberculosis mycobacteria(NTM)among the samples deposited from the National Tuberculosis Reference Laboratory of Iran between 2011 and 2018.Methods:The study evaluated th... Objective:To investigate the prevalence of non-tuberculosis mycobacteria(NTM)among the samples deposited from the National Tuberculosis Reference Laboratory of Iran between 2011 and 2018.Methods:The study evaluated the prevalence of NTM among specimens from patients with pulmonary tuberculosis symptoms(n=15771)deposited at the National Tuberculosis Reference Laboratory of Iran from 2011 to 2018.Detection of Mycobacterium(M.)tuberculosis was based on presence of a 190-bp amplicon from IS6110 insertion sequence using Tb1 and Tb2 primers,and amplicon-negative specimens were tested for NTM and M.tuberculosis(refractory to IS6110 amplification)using restriction fragment length polymorphism PCR of hsp65 amplicon fragment.Results:A total of 7307(46.33%)M.tuberculosis and 658(4.17%)NTM specimens were found,the latter mainly comprising M.abscessus(10.18%),M.avium(2.28%),M.chelonae(8.97%),M.intracellulare(10.49%),M.kansasii(4.71%),and M.simiae(56.08%).Conclusions:As treatment for NTM differs from that for M.tuberculosis,accurate detection of Mycobacterium sp.is of public health significance. 展开更多
关键词 Diagnosis Iran non-tuberculosis Mycobacterium PREVALENCE
下载PDF
Characterization of Mycobacterium Species Circulating among Tuberculosis Patients in Bayelsa State, Nigeria
2
作者 Smart Enoch Amala Goodluck Silas +1 位作者 Amba Ollor Ollor Vivian Nkemkanma Agi 《Journal of Tuberculosis Research》 2023年第3期95-108,共14页
Introduction: Tuberculosis is caused by infection with Mycobacterium tuberculosis. Looking at the evolution of the bacterium gene due to mutation is crucial to identify species circulating among patients in an area. W... Introduction: Tuberculosis is caused by infection with Mycobacterium tuberculosis. Looking at the evolution of the bacterium gene due to mutation is crucial to identify species circulating among patients in an area. WHO speculated that tuberculosis is caused by M. tuberculosis (MTB), but identification of the strains of MTB circulating in a particular area is important for the management of MTB and to identify pulmonary infections caused by non-tuberculosis mycobacterium. Contact tracing of drug resistant MTB in circulation in an area is also an important procedure of MTB therapeutic choice. Aim: This study aimed to isolate and identify Mycobacterium species circulating in Bayelsa State, Nigeria. Materials and Methods: A total of 102 sputum samples collected from MTB patients were cultured in Lowenstein Jensen (LJ) solid media. Isolates on LJ media were confirmed using Zeihl Nelseen staining method for AFB and Standard Diagnosis Bioline TB Ag MPT64 Rapid test kit. The 16s rRNA gene amplification, agarose gel electrophoresis, and gene sequencing were conducted. Phylogenic analysis and evolutional distances of the strains are computed using the Juke-cantor method. Result: Out of 102 sputum samples examined 15 (14.7%) had growth of Mycobacterium species (AFB positive). The extracted DNA of MTB amplified on agarose gel electrophoresis aligned horizontally at lanes 1 - 15 showing 16S gene band (1500 bp). Two 2 (2.0%) are non-tuberculosis Mycobacteria species, while 13 (12.7%) were M. tuberculosis. The non-tuberculosis Mycobacterium species isolated are Mycobacteriode abscesses and Mycobacterium kansassii strain FDAARGOS 1534. The tuberculosis strains are Mycobacterium tuberculosis MG003 and R2092 but the predominant strain was MG003. The degree of the genetic evolution of the non-MTB Mycobacterium kansassii strain FDAARGOS 1534 was 75.4%. Conclusion: The two major strains of Mycobacterium tuberculosis (MTB) circulating in Bayelsa State are MTB MG003 and MTB R2092;MTB MG003 was predominant. The non-tuberculosis species are Mycobacteriode abscesses and Mycobacterium kansasii. 展开更多
关键词 TUBERCULOSIS non-tuberculosis STRAINS CIRCULATING Bayelsa
下载PDF
44株甘肃疑似非结核分枝杆菌临床分离株的菌种鉴定 被引量:12
3
作者 连璐璐 姜元 +7 位作者 赵秀芹 同重湘 余琴 张敬蕊 董海燕 张媛媛 吴移谋 万康林 《中国人兽共患病学报》 CAS CSCD 北大核心 2013年第4期343-348,共6页
目的对甘肃44株疑似非结核分枝杆菌临床分离株进行菌种鉴定。方法收集2010年甘肃省兰州市胸科医院从结核病患者痰标本中分离的、抗酸染色阳性和改良罗氏培养基,TCH和PNB鉴别培养基培养鉴定为非结核分枝杆菌(non-tuberculosis Mycobacter... 目的对甘肃44株疑似非结核分枝杆菌临床分离株进行菌种鉴定。方法收集2010年甘肃省兰州市胸科医院从结核病患者痰标本中分离的、抗酸染色阳性和改良罗氏培养基,TCH和PNB鉴别培养基培养鉴定为非结核分枝杆菌(non-tuberculosis Mycobacteria,NTM),采用rpoB-PRA和PCR产物DNA测序等分子生物学方法进行细菌种的鉴定。结果共对44株疑似非结核分枝杆菌临床分离株进行了鉴定。经rpoB-PRA、rpoB和hsp65基因DNA测序分析,其中非结核分枝杆菌13株(29.55%),包括龟分枝杆菌(M.chelonae)5株,戈登分枝杆菌(M.gordonae)4株,胞内分枝杆菌(M.intracellulare)2株,赛特分枝杆菌(M.setense)1株,耻垢分枝杆菌(M.smegmatis)1株;诺卡菌(Nocardia)31株(70.45%),其中鼻疽诺卡菌(N.farcinica)30株,卡尔涅亚诺卡菌(N.carnea)1株。结论抗酸染色阳性、PNB/TCH鉴定为非结核分枝杆菌临床分离株中包含不同种类的非结核分枝杆菌和诺卡菌,应开展进一步菌种鉴定,以便于临床正确诊断和合理治疗。 展开更多
关键词 非结核分枝杆菌 诺卡菌 鉴定 RPOB PRA
下载PDF
广州市越秀区及海珠区非结核分枝杆菌流行状况 被引量:10
4
作者 童莉 谭守勇 +2 位作者 刘志辉 黄业伦 黎燕琼 《实用医学杂志》 CAS 北大核心 2015年第13期2211-2213,共3页
目的:了解广州市越秀区及海珠区非结核分枝杆菌流行状况。方法:回顾性对广州市越秀区、海珠区两个结核病防治所2010-2012年就诊的痰抗酸杆菌涂片阳性可疑肺结核患者,进行痰结核分枝杆菌培养及菌种鉴定,分析肺结核诊断的准确性。结果:201... 目的:了解广州市越秀区及海珠区非结核分枝杆菌流行状况。方法:回顾性对广州市越秀区、海珠区两个结核病防治所2010-2012年就诊的痰抗酸杆菌涂片阳性可疑肺结核患者,进行痰结核分枝杆菌培养及菌种鉴定,分析肺结核诊断的准确性。结果:2010-2012年共2 014例痰涂片及培养抗酸杆菌阳性,1 630例(80.9%)为结核分枝杆菌复合群(MTC),384例(19.1%)为非结核分枝杆菌(NTM)。2010-2012各年度痰培养抗酸杆菌阳性菌株中,NTM分离率分别为17.6%、17.1%、21.2%。384株NTM中共有79株进行了NTM菌种或复合群鉴定,快速生长型分枝杆菌占50.6%,慢速生长型分枝杆菌占49.4%。结论:广州市越秀区、海珠区可疑肺结核患者痰标本中NTM分离率为19.1%。临床上对涂阳肺结核患者疗效欠佳时,应及时排除非结核分枝杆菌肺病。 展开更多
关键词 分枝杆菌 流行病学 非结核
下载PDF
免疫支持对非结核分枝杆菌肺病患者疗效影响 被引量:3
5
作者 江万航 刘国标 +1 位作者 杜正新 李方知 《广州医药》 2017年第2期17-19,共3页
目的了解非结核分枝杆菌(nontuberculous mycobacteria,NTM)肺病患者免疫功能低下发生率,以及免疫支持的应用状况、探讨免疫支持治疗对患者2月末痰菌阴转及病变吸收的影响,为临床实施免疫干预提供参考依据。方法分析广州市胸科医院2014... 目的了解非结核分枝杆菌(nontuberculous mycobacteria,NTM)肺病患者免疫功能低下发生率,以及免疫支持的应用状况、探讨免疫支持治疗对患者2月末痰菌阴转及病变吸收的影响,为临床实施免疫干预提供参考依据。方法分析广州市胸科医院2014年1月—2015年12月确诊的资料完整的381例NTM肺病患者免疫功能情况以及免疫支持的应用状况,观察组(加用免疫调节剂母牛分枝杆菌菌苗)228例与同期对照组(未使用免疫调节剂)153例进行2月末痰菌阴转及病变吸收情况比较。结果 381例患者中,免疫功能低下的发生率为45.67%(174/381);免疫支持率为59.84%(228/381)。细菌学改变:治疗前所有患者痰抗酸杆菌涂片和培养均为阳性。治疗2个月后两组的阴转率分别为67/228(29.38%)、17/153(11.11%),χ~2=17.79,P<0.05。影像学改变:两组的病变吸收有效率分别为62/228(27.19%)、16/153(10.45%),χ~2=15.75,P<0.05;空洞吸收有效率分别为61/228(26.75%)、15/153(9.80%),χ~2=20.42,P<0.05。结论非结核分枝杆菌肺病患者存在较高比例的免疫功能低下风险,观察组的痰茵阴转、病灶吸收和空洞闭合的疗效高于对照组。 展开更多
关键词 非结核分枝杆菌肺病 住院患者 免疫功能低下风险 免疫支持
下载PDF
First Report in China on the Identification and Drug Sensitivity of Mycobacterium elephantis Isolated from the Milk of a Cow with Mastitis 被引量:1
6
作者 JI Ling Yun XU Dong Lei +8 位作者 YIN Shu Peng LIU Hai Can LI Gui Lian JIANG Yi WEI Jian Hao ZENG Hao LOU Yong Liang LYU Jian Xin WAN Kang Lin 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2017年第7期501-507,共7页
Objective In this study, milk from a cow with mastitis was analyzed to determine the presence of mycobacterial infection. Milk quality and security problems pertaining to the safe consumption of dairy products were al... Objective In this study, milk from a cow with mastitis was analyzed to determine the presence of mycobacterial infection. Milk quality and security problems pertaining to the safe consumption of dairy products were also discussed in this study. Methods Milk was preprocessed with 4% NaOH. Then, mycobacteria were isolated from the milk sample on L-J medium. The isolate was identified using multiple loci Polymerase Chain Reaction (PCR) and multi-locus sequence analysis with 16S rRNA, sodA, hsp65, and ITS genes. The drug sensitivity of the isolate to 27 antibiotics was tested through alamar blue assay. Results Smooth, moist, pale yellow colonies appeared on the L-J medium within a week after inoculation. Based on the results of multiple loci PCR analysis, the isolate was preliminarily identified as non-tuberculous mycobacteria. The 16S rRNA, SodA, hsp65, and ITS gene sequences of the isolate exhibited 99%, 99%, 99%, and 100% similarities, respectively, with those of the published reference strains of Mycobacteriurn elephantis (M. elephantis). The drug sensitivity results showed that the strain is resistant to isoniazid, p-aminosalicylic acid, and trimesulf but is sensitive to ofloxacin, rifampicin, amikacin, capreomycin, moxifloxacin, kanamycin, levofloxacin, cycloserine, ethambutol, streptomycin, tobramycin, rifabutin, ciprofloxacin, linezolid, cefoxitin, clarithromycin, and minocycline. Conclusion To the best of our knowledge, this study is initially to report the isolation of M. elephantis from the milk of a cow with mastitis in China. 展开更多
关键词 Key words: non-tuberculosis mycobacterium Mycobacterium elephantis MILK Cow mastitis
下载PDF
Pathological humerus fracture due to anti-interferon-gamma autoantibodies:A case report 被引量:1
7
作者 Cheng Hsun Yang Feng-Chih Kuo Chen-Hsiang Lee 《World Journal of Orthopedics》 2021年第11期938-944,共7页
BACKGROUND Various etiologies contribute to pathological fractures,including bone infections.Recently,non-tuberculosis Mycobacterium-related bone infections among patients with anti-interferon-gamma autoantibody-induc... BACKGROUND Various etiologies contribute to pathological fractures,including bone infections.Recently,non-tuberculosis Mycobacterium-related bone infections among patients with anti-interferon-gamma autoantibody-induced adult-onset immunodeficiency has raised concerns in Southeast Asia,with the common presentations including osteomyelitis.However,it also rarely manifests as traumatic fractures,as reported in this case.CASE SUMMARY A diabetic female fractured her humerus after a traumatic accident and received fixation surgery.Abnormal necrotic bone tissue and abscess formation were noted,and she was diagnosed with a pathological fracture due to nontuberculosis Mycobacterium infection.Multiple bone involvement was also revealed in a bone scan.Anti-interferon-gamma autoantibodies were then checked due to an unexplained immunocompromised status and found to be positive.Her humerus fracture and multiple bone infections healed after steroid and anti-non-tuberculosis Mycobacterium medication treatment following fixation surgery.CONCLUSION Comprehensive preoperative evaluations may help identify pathological fractures and guide the treatment course. 展开更多
关键词 Immunocompromised status Neutralizing anti-interferon-gamma autoantibody non-tuberculosis mycobacterium Pathological fracture Pre-operative evaluations Case report
下载PDF
Genitourinary Bacillus Calmette-Guerin Infection after BCG Intravesical Administration in a Patient under Hemodialysis—What Can We Do Better?
8
作者 Lúcia Ribeiro Dias Catarina Almeida +5 位作者 Fernando Nogueira Rita Soares Sofia Garcês Soares Maria Lima Costa Maria Teresa Boncoraglio Filipa Ceia 《Advances in Infectious Diseases》 CAS 2022年第3期563-567,共5页
A 74-year-old man with terminal chronic kidney disease, under hemodialysis and with residual diuresis, was admitted due to myalgia, arthralgia, fever and pyuria in the previous 10 days. The patient had a recent diagno... A 74-year-old man with terminal chronic kidney disease, under hemodialysis and with residual diuresis, was admitted due to myalgia, arthralgia, fever and pyuria in the previous 10 days. The patient had a recent diagnosis of high-grade non-invasive bladder cancer and was doing weekly BCG intravesical administrations. The symptoms started three days before the fifth administration. He had done cefixime as an outpatient and started piperacillin-tazobactam on hospital admission, but the fever persisted, and there was no bacterial isolation in urine or blood culture. On the tenth and seventeenth day after the last BCG intravesical administration Mycobacterium bovis was still isolated in the urine culture. The diagnosis of BCGitis was made and treatment was started, with a good response. Forty days after the last administration and under treatment, the culture remained positive for Mycobacterium bovis in the urine. We raise the question about the safety of BCG administration in patients with residual diuresis. 展开更多
关键词 BCGitis Mycobacterium Bovis HEMODIALYSIS non-tuberculosis Mycobacterium Bladder Cancer
下载PDF
Saccharomyces boulardii Produces a Factor That Inhibits Mycobacterium intracellulare Burden in Human Macrophages
9
作者 An Bai Michael Weaver +2 位作者 Fukai Bao Edward D. Chan Xiyuan Bai 《Advances in Microbiology》 2016年第13期965-974,共11页
Lung disease caused by Non-Tuberculosis Mycobacteria (NTM) is increasing in prevalence. NTM lung disease is notable for poor response to therapy. Saccharomyces boulardii is probiotic that can be effective in inflammat... Lung disease caused by Non-Tuberculosis Mycobacteria (NTM) is increasing in prevalence. NTM lung disease is notable for poor response to therapy. Saccharomyces boulardii is probiotic that can be effective in inflammatory gastrointestinal disease with diverse pathophysiology. The present study investigated the effects of the products of S. boulardii-B508 on burden of NTM-Mycobacterium intracellulare complex in human macrophage infection in vitro. It was found that the supernatant of S. boulardii-B508 inhibited the growth of Mycobacterium intracellulare in human macrophage infection and induced infected cell apoptosis. The data of RT-PCR showed that the products of S. boulardii-B508 inhibited IL-8 expression during M. intracellulare infection in human macrophages due to its effects on NF-kB activation. To the best of our knowledge, this is the first report of effective products of S. boulardii on NTM infection in human macrophage. S. boulardii possesses anti-NTM lung disease properties in human macrophage worthy of further evaluation in clinical studies. 展开更多
关键词 Saccharomyces boulardii non-tuberculosis Mycobacteria Nuclear-Factor Kappa B
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部